Crohn's Disease can show evidence of ongoing disease activity even during remission, as indicated by the presence of immunocompetent cells and elevated levels of the cytokine TNF-α in the intestinal mucosa. While colonoscopies can provide clues to disease activity, they may not reveal specific indicators if no prior diagnosis exists. Evidence of prior disease activation can include personal and family medical history, as well as physical signs like fistulas and intestinal wall thickening. Clinical remission is defined by the absence of symptoms, which correlates with mucosal healing. However, studies suggest that immune activation markers may persist during remission, potentially indicating a risk for early relapse. Current research is exploring the relationship between immune activation and clinical outcomes in Crohn's Disease management.